Westhouse Medical Services Plc (HAM:5WM) Announces Appointment of Mr Kevin Riches as New Non-Executive Director

RELATED QUOTES

SymbolPriceChange

London, United Kingdom, Dec 10, 2012 - (ABN Newswire) - Healthcare specialist Westhouse Medical Services Plc (HAM:5WM.F - News) today announces the appointment of Mr Kevin Riches as Non-Executive Director. Kevin has over 25 years experience in start up and mature businesses, both large and small.

The sectors have ranged from IT and communications through environmental and finance to PFI in hospitals and Education.

Kevin has a proven track record as a change agent and has an excellent, mature network of business leaders, contacts and partners. Recent successful business engagements include SpinVox, Dennis Publishing, Carteme, Phones 4 U, PRS and PTS Consulting.

He is a Director and Shareholder at European American Capital, Carteme, Applied Cytometry, Plasma Europe and at Waterbridge Capital

Kevin is passionate about value creation, often at a consumer level, usually delivered via B2B relationships.

Westhouse is currently developing a number of medical devices, including BreastCheck - a new low-cost, non-invasive breast cancer screening product which can act as a precursor to mammogram scanning. BreastCheck is due for launch in 2013.

Westhouse recently acquired from US-listed Sunridge International via. Sunridge's subsidiary, Ophthalmic International Inc, a glaucoma procedure called PNT, which could revolutionise the way glaucoma is treated globally.

WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4

~ends~

About Westhouse Medical Services Plc:

Westhouse Medical (FRA:5WM.F - News) consists of two wholly-owned subsidiaries: Westhouse Medical Ltd and Westhouse Medical Devices Ltd. Westhouse is expanding rapidly through the acquisition and expansion of primary healthcare businesses within Europe and North America". Westhouse Medical Services Plc has a dynamic range of Medical Services and Devices providing cutting edge innovation in the medical sectors such as a non-invasive
Test for Breast Cancer and a patented procedure to treat glaucoma. www.westhousemedical.com

Contact:

 
For press information, contact: 
Global Press and Public Relations: 

Gabriel Luca 
Wedgewood Communications 
60 Madison Avenue 
Suite 1212 
New York 
NY 10010 USA                     
Tel: +1 646 592 7559
westhouse@wwprnews.com 

Source:

Westhouse Medical Services Plc

Copyright (C) 2012 ABN Newswire. All rights reserved.

Market Data

  • Currencies
    Currencies
    NamePriceChange% Chg
    0.9270-0.0017-0.18%
    AUDUSD=X
    0.5519-0.0015-0.28%
    AUDGBP=X
    0.6707-0.0014-0.21%
    AUDEUR=X
  • Commodities
    Commodities
    NamePriceChange% Chg